Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial.

Abstract

BACKGROUND Adherence is key to the success of antiretroviral therapy. Enhanced partner support might benefit patients with previous treatment failure. We aimed to assess whether an enhanced partner-based support intervention with modified directly observed therapy would improve outcomes with second-line therapy in HIV-infected patients for whom first-line… (More)
DOI: 10.1016/S2352-3018(14)00007-1

Topics

Statistics

020406020162017
Citations per Year

Citation Velocity: 13

Averaging 13 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Gross2015PartnerbasedAI, title={Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial.}, author={Robert Gross and Lu Zheng and Alberto La Rosa and Xin Sun and Susan L. Rosenkranz and Sandra Wagner Cardoso and Francis Ssali and R D R Camp and Catherine Godfrey and Susan E. Cohn and Gregory K. Robbins and Anthony Chisada and Carole Lorraine Wallis and Nancy R. Reynolds and Darlene Lu and Steven A. Safren and Lara Hosey and Patrice D Severe and Ann C Collier}, journal={The lancet. HIV}, year={2015}, volume={2 1}, pages={e12-9} }